Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...

BOTHELL, WASHINGTON / / July 10, 2025 / Innovative EV Technologies, Inc., formerly VaporBrands International, Inc. dba ...

The popularity of rustic sourdough, small-batch oat milk and premium grocery-store pastries are not simply trends. They are ...